Top-News
Pharmazeutika USA

ANI Pharmaceuticals Inc Aktie

Aktie
WKN:  A1W15D ISIN:  US00182C1036 US-Symbol:  ANIP
58,00 €
+1,00 €
+1,75%
14.03.25
Depot/Watchlist
Aktienanzahl *
21,03 Mio.
Marktkapitalisierung *
1,21 Mrd. €
Streubesitz
-10,18%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 26.08.2024

ANI Pharmaceuticals Inc News

13.01.25 - PR Newswire
Alcami Announces CEO Transition
Alcami Announces CEO Transition PR Newswire
20.05.24 - PR Newswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) PR Newswire
14.02.22 - PR Newswire
Oakrum Pharma and ANI Pharmaceuticals Announce the Launch of Betaine Anhydrous Powder, the first Generic Version of Cystadane® (betaine anhydrous for oral solution) Powder, Including 180 Days of Exclusivity
Oakrum Pharma and ANI Pharmaceuticals Announce the Launch of Betaine Anhydrous Powder, the first Generic Version of Cystadane® (betaine anhydrous for oral solution) ...
06.07.20 - PR Newswire
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets
ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets PR Newswire
30.06.20 - PR Newswire
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules PR Newswire
01.06.20 - PR Newswire
ANI Pharmaceuticals Provides Update on Recent Regulatory Filing
ANI Pharmaceuticals Provides Update on Recent Regulatory Filing PR Newswire
07.05.20 - PR Newswire
ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO
ANI Pharmaceuticals Reports First Quarter 2020 Results and Appoints Interim CEO PR Newswire
30.04.20 - PR Newswire
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results
ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2020 Financial Results PR Newswire
29.04.20 - PR Newswire
ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel
ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel PR Newswire
13.04.20 - PR Newswire
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL FDA Sets Prescription Drug User Fee Act (PDUFA) Goal Date of July 23, 2020 PR Newswire
26.03.20 - PR Newswire
ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet
ANI Announces Launch of Polyethylene Glycol 3350, 17g/Packet PR Newswire
24.03.20 - PR Newswire
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL PR Newswire
02.03.20 - PR Newswire
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-​Release Capsules PR Newswire
27.02.20 - PR Newswire
ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020
ANI Pharmaceuticals Reports Full Year and Fourth Quarter 2019 Results, Provides 2020 Guidance and Remains on Track to Submit Cortrophin® Gel sNDA to FDA in March 2020 ...
20.02.20 - PR Newswire
ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-to-Date 2019 Financial Results
ANI Pharmaceuticals Schedules Conference Call to Discuss Fourth Quarter and Year-​to-Date 2019 Financial Results PR Newswire
12.02.20 - PR Newswire
ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL
ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL PR Newswire
16.01.20 - PR Newswire
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-Release Tablets USP
ANI Pharmaceuticals Announces FDA Approval of Potassium Citrate Extended-​Release Tablets USP PR Newswire
14.01.20 - PR Newswire
ANI Announces Launch of Paliperidone Extended-Release Tablets
ANI Announces Launch of Paliperidone Extended-​Release Tablets PR Newswire
18.12.19 - PR Newswire
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL PR Newswire
26.11.19 - PR Newswire
ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference
ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference PR Newswire

Newssuche

Videos

newspaper
12.03.25 +158,93%
Technical Trading: Saisonaler Top Trade
S&P 500 Long Typ: Turbo Open End WKN: NG9CZA Hebel: 38 Laufzeit: OpenEnd Einstieg: Market ... Mehr »